Tirzepatide for Obesity in Adults Without Diabetes

The study is designed to evaluate the effectiveness of a medication called tirzepatide in helping people with obesity lose weight and prevent the onset of type 2 diabetes. This study specifically focuses on adults who are obese and have at least one other health condition related to their weight, but who do not currently have diabetes. By testing tirzepatide in a real-world setting, the study aims to see if this treatment can offer a new, effective option for weight management and diabetes prevention in this population. Participants in this study will take tirzepatide once a week. The study will compare the results of those taking tirzepatide with those receiving standard care for obesity. Researchers will primarily look at changes in body weight from the start of the study to see how effective the treatment is. The study will last about 260 weeks, allowing enough time to observe long-term effects and any potential benefits of this treatment approach.